The AI boom has hit across industries, and public sector organizations are facing pressure to accelerate adoption. At the same time, government institutions face distinct constraints around security, governance, and operations that set them apart from their business counterparts. For this reason, purpose-built small language models (SLMs) offer a promising path to operationalize AI in […]
Lilly says Foundayo safety confirmed in ACHIEVE-4 trial
Eli Lilly’s ACHIEVE-4 trial results for oral GLP-1 Foundayo set up a filing in diabetes, and provide safety data sought by the FDA.
Why having “humans in the loop” in an AI war is an illusion
The availability of artificial intelligence for use in warfare is at the center of a legal battle between Anthropic and the Pentagon. This debate has become urgent, with AI playing a bigger role than ever before in the current conflict with Iran. AI is no longer just helping humans analyze intelligence. It is now an […]
Lilly’s obesity pill heads for diabetes filing after heart risk trial
Eli Lilly’s recently approved obesity pill Foundayo cut the risk of cardiovascular events like heart attack and stroke by 16% versus a form of insulin, new data show, and the company is planning to file …
Beeline raises $300m for BMS drugs, and other biofinancings
Beeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week.
Most patients “won’t see benefit” with Alzheimer’s drugs
A review of clinical data on amyloid-targeting Alzheimer’s therapies has found absent or trivial efficacy, but is facing pushback from some experts.
Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
Omnicom Health has stamped its mark on the recently acquired FCB Health New York, rebranding the ad agency as Olixir New York in the aftermath of the mega-merger with Interpublic Group.
Freya Biosciences advances microbial treatment for IVF implantation failure
Freya Biosciences is moving a microbial immunotherapy for IVF implantation failure into mid-stage trials after promising results in healthy volunteers. The Phase 2 study is testing Freya’s candidate, called FB301, in women with vaginal dysbiosis …
6-Year Ransomware Campaign Targets Turkish Homes & SMBs
While enterprises breaches make more headlines, smaller incidents tend to be under-reported, if at all, allowing campaigns to last longer with less disruption.
L2D-Clinical: Learning to Defer for Adaptive Model Selection in Clinical Text Classification
arXiv:2604.13285v1 Announce Type: cross Abstract: Clinical text classification requires choosing between specialized fine-tuned models (BERT variants) and general-purpose large language models (LLMs), yet neither dominates across all instances. We introduce Learning to Defer for clinical text (L2D-Clinical), a framework that learns when a BERT classifier should defer to an LLM based on uncertainty signals and […]
Young people’s perceptions and recommendations for conversational generative artificial intelligence in youth mental health
arXiv:2604.13381v1 Announce Type: cross Abstract: Conversational generative artificial intelligence agents (or genAI chatbots) could benefit youth mental health, yet young people’s perspectives remain underexplored. We examined the Mental health Intelligence Agent (Mia), a genAI chatbot originally designed for professionals in Australian youth services. Following co-design, 32 young people participated in online workshops exploring their perceptions […]
The Mirror Design Pattern: Strict Data Geometry over Model Scale for Prompt Injection Detection
arXiv:2603.11875v2 Announce Type: replace-cross Abstract: Prompt injection defenses are often framed as semantic understanding problems and delegated to increasingly large neural detectors. For the first screening layer, however, the requirements are different: the detector runs on every request and therefore must be fast, deterministic, non-promptable, and auditable. We introduce Mirror, a data-curation design pattern that […]